Cite
HARVARD Citation
Cohen, S. et al. (2018). Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE®-RL). Expert opinion on drug delivery. pp. 545-548. [Online].